Phase I trial with carboplatin and RAD001 in metastatic breast cancer

被引：0
|
作者：
Eucker, J.
Schwarzlose-Schwarck, S.
Martus, P.
Regierer, A. C.
Schulz, C. O.
Liu, H.
Scholz, C. W.
Schefe, J. H.
Possinger, K.
机构：
[1] Charite, Dept Hematol & Oncol, Berlin, Germany
[2] Charite, Inst Biostat & Clin Epidemiol, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e11554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11554
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II Trial of RAD001 Plus Carboplatin in Patients with Triple-Negative Metastatic Breast Cancer
    Singh, J. C.
    Stein, S.
    Volm, M.
    Smith, J.
    Novik, Y.
    Speyer, J.
    Adams, S.
    Meyers, M.
    Muggia, F.
    Schneider, R.
    Formenti, S.
    Omene, C.
    Choi, H.
    Davis, S.
    Goldberg, J.
    Tiersten, A.
    [J]. CANCER RESEARCH, 2011, 71
  • [2] Phase II trial of RAD001 plus carboplatin in patients with triple-negative metastatic breast cancer.
    Singh, Jasmeet Chadha
    Stein, Stacy
    Volm, Matthew
    Smith, Julia Anne
    Novik, Yelena
    Speyer, James L.
    Meyers, Marlene
    Adams, Sylvia
    Omene, Coral Oghenerukevwe
    Muggia, Franco
    Schneider, Robert
    Formenti, Silvia
    Davis, Samantha
    Beardslee, Brian
    Tiersten, Amy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Efficacy of RAD001/carboplatin in triple-negative metastatic breast cancer: A phase II study
    Singh, Jasmeet Chadha
    Volm, Matthew
    Novik, Yelena
    Speyer, James L.
    Adams, Sylvia
    Omene, Coral Oghenerukevwe
    Meyers, Marleen Iva
    Smith, Julia Anne
    Schneider, Robert
    Formenti, Silvia
    Goldberg, Judith D.
    Li, Xiaochun
    Davis, Samantha
    Beardslee, Brian
    Tiersten, Amy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [4] A Phase 2 trial of RAD 001 and Carboplatin in patients with triple negative metastatic breast cancer
    Singh, J. C.
    Volm, M.
    Novik, Y.
    Speyer, J.
    Adams, S.
    Omene, C. O.
    Meyers, M.
    Smith, J. A.
    Schneider, R.
    Formenti, S.
    Goldberg, J. D.
    Li, X.
    Davis, S.
    Beardslee, B.
    Tiersten, A.
    [J]. CANCER RESEARCH, 2012, 72
  • [5] Phase I trial of escalating doses of weekly everolimus (RAD001) in combination with docetaxel for the treatment of metastatic breast cancer (MBC)
    Moulder, S. L.
    Rivera, E.
    Ensor, J.
    Gonzalez-Angulo, A.
    Christofanilli, M.
    Booser, D.
    Giordano, S.
    Brewster, A.
    Hortobagyi, G.
    Tran, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
    Taekyu Lim
    Jeeyun Lee
    Duk Joo Lee
    Ha Yeon Lee
    Boram Han
    Kyung Kee Baek
    Hee Kyung Ahn
    Su Jin Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Kyoung-Mee Kim
    Won Ki Kang
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 68 : 255 - 262
  • [7] Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
    Lim, Taekyu
    Lee, Jeeyun
    Lee, Duk Joo
    Lee, Ha Yeon
    Han, Boram
    Baek, Kyung Kee
    Ahn, Hee Kyung
    Lee, Su Jin
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Kyoung-Mee
    Kang, Won Ki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 255 - 262
  • [8] A Phase I Pilot Study of the Oral mTOR Inhibitor RAD001 in Combination with Capecitabine for Metastatic Breast Cancer.
    Chen, C. S.
    Chen, M. M.
    Imaoka, R. T.
    Svahn, T.
    Guardino, A. E.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 860S - 860S
  • [9] Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma
    Kroog, G. S.
    Feldman, D. R.
    Kondagunta, G. V.
    Ginsberg, M. S.
    Fischer, P. M.
    Trinos, M. J.
    Patil, S.
    Ishill, N. M.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial
    Singh, Jasmeet Chadha
    Stein, Stacy
    Volm, Matthew
    Smith, Julia Anne
    Adams, Sylvia
    Meyers, Marlene
    Speyer, James L.
    Novik, Yelena
    Schneider, Robert
    Formenti, Sylvia
    Muggia, Franco
    Jhaveri, Komal L.
    Goldberg, Judith D.
    Heese, Scott
    Li, Xiaochun
    Davis, Samantha
    Tiersten, Amy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345